Anhco Nguyen's Insider Trades & SAST Disclosures
Anhco Nguyen's most recent trade in Atara Biotherapeutics Inc was a trade of 3,276 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on May 16, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Anhco Nguyen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 16 May 2025 | 3,276 | 70,847 (0%) | 0% | 6.8 | 22,156 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 03 Mar 2025 | 3,331 | 74,123 (0%) | 0% | 7.0 | 23,307 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 18 Nov 2024 | 1,664 | 77,454 (0%) | 0% | 11.2 | 18,633 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2024 | 45,000 | 79,118 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 16 Aug 2024 | 1,468 | 34,471 (0%) | 0% | 6.6 | 9,731 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 16 Aug 2024 | 297 | 34,174 (0%) | 0% | 6.6 | 1,969 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 16 Aug 2024 | 56 | 34,118 (0%) | 0% | 6.6 | 371 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 16 May 2024 | 42,899 | 898,498 (1%) | 0% | 0.6 | 26,469 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Mar 2024 | 10,746 | 941,397 (1%) | 0% | 0.7 | 7,737 | Common Stock |
| Atara Biotherapeutics Inc | Nguyen Anhco | EVP, Chief Sci. & Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 675,000 | 952,143 (1%) | 1% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges